Composition & Specifications
Dapagliflozin Sitagliptin Metformin Hydrochloride Tablets
Advanced Type 2 Diabetes Management
Dapagliflozin Sitagliptin Metformin Hydrochloride Tablets are a powerful triple-drug combination designed for effective management of Type 2 Diabetes Mellitus. This advanced formulation helps control blood glucose levels through three complementary mechanisms, offering better and more consistent glycemic control. It is commonly prescribed when single or dual therapy does not provide adequate blood sugar management.
This triple combination works in a scientifically coordinated way:
- Dapagliflozin removes excess glucose from the body through urine by inhibiting SGLT2 in the kidneys.
- Sitagliptin increases insulin release and lowers glucagon levels by blocking the DPP-4 enzyme.
- Metformin Hydrochloride reduces glucose production in the liver and improves insulin sensitivity.
Together, these medicines help control both fasting and post-meal blood sugar levels effectively.
- ✔ Triple-action blood sugar control ✔ Significant HbA1c reduction ✔ Lower risk of hypoglycemia (when prescribed properly) ✔ May support weight management ✔ Convenient dosage for improved compliance
This combination offers a comprehensive solution for patients requiring stronger glycemic management.
Who Should Use This Combination?
Dapagliflozin Sitagliptin Metformin Tablets are recommended for adults with Type 2 Diabetes who:
- Are not achieving target sugar levels with Metformin alone
- Require combination therapy for better glucose stability
- Have insulin resistance and elevated blood sugar
Doctors prescribe this therapy along with lifestyle changes such as proper diet and regular exercise.
Safety and Precautions
This medication should only be taken under medical supervision. Regular monitoring of blood glucose levels, kidney function, and overall metabolic health is important during treatment. Some patients may experience mild side effects such as nausea, urinary tract symptoms, or stomach discomfort. Consult a healthcare provider if symptoms persist or worsen.
Conclusion
Dapagliflozin Sitagliptin Metformin Hydrochloride Tablets provide an advanced and reliable option for managing Type 2 Diabetes. With triple-action support, this combination helps patients achieve stable blood sugar control and better long-term health outcomes.
📋 Certificate of AnalysisBatch-specific CoA from NABL-accredited lab available for every product.
🏅 GMP Schedule MManufactured under Drugs & Cosmetics Act GMP Schedule M standards.
🔬 Third-Party TestedEvery batch independently tested by NABL-accredited laboratory before dispatch.
📞 Request Product Dossier — For full composition details, pack sizes, and franchise pricing, contact us on
+91-8729000609 or
WhatsApp us.
Prescribing & Administration Information
⚠️ For Healthcare Professionals & Franchise Partners Only: This product is sold through licensed PCD franchise partners and authorised stockists. Prescribing, dosage, and administration information is available in the product literature and Patient Information Leaflet (PIL) supplied with each batch.
Dosage & Administration
As directed by the prescribing physician. Dosage varies by indication, patient age, and clinical condition. Full prescribing information included with product.
Storage Conditions
Store in a cool, dry place below 25°C, away from direct sunlight and moisture. Keep out of reach of children. Do not use after expiry date printed on the pack.
Available Documentation
📄Product Information Leaflet (PIL) — included with every batch
🔬NABL-accredited Certificate of Analysis (CoA) — available on request per batch
📋Drug License compliance documents — provided with franchise agreement
🏅WHO-GMP manufacturing certificate — available for regulatory submission
